Dalmia Bharat Q4 Results: Stock falls 4% on topline miss, but margins expand
Dalmia Bharat’s EBITDA margins expanded to 20.7% from 19.3% in the year-ago period and were also higher compared to street estimates of 19.5%.
admin
The last PE fund on Mobikwik’s cap table makes an exit after Tuesday’s block deal
Peak XV was the last remaining PE fund on MobiKwik’s cap table, after the Abu Dhabi Investment Authority had made an exit in September last year.
Domestic gold, silver prices slip amid cautious global outlook ahead of Fed decision
Gold and silver prices eased in India and globally as investors await US Federal Reserve signals, with geopolitical tensions and inflation worries keeping volatility elevated.
Paras Defence partners Complus, JV Micronics for anechoic chamber projects
Paras Defence signs MoU with Complus Systems and JV Micronics to build anechoic chambers in India and abroad, leads consortium, shares rise 0.64% to ₹813.30.
Unicommerce shares down 9% as Q4 margins shrink on high investments
The margin compression was largely due to planned investments in Shipway, which operates at lower margins and weighed on overall profitability.
Markets may have bottomed; commodities in focus, IT underweight: Bajaj Finserv AMC
Bajaj Finserv AMC CIO Nimesh Chandan highlighted commodities as a key sector due to supply constraints and demand trends, while remaining cautious on IT. He also sees opportunities in defence, healthcare, and metals over the medium term.
Piramal Finance shares jump 11% after strong Q4; stock has no ‘sell’ ratings
Of the nine analysts that have coverage on Piramal Finance, seven of them have a ‘Buy’ rating, while two recommends ‘Hold’ on the stock.
Eternal Q4 Results: Stock at day’s low ahead of earnings; Here are the key factors
As per the CNBC-TV18 poll, Eternal’s revenue is likely to go up by 5.1% from the December quarter to ₹17,155 crore, while its Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) is likely to rise 8.7% from the previous quarter…
Cohance Lifesciences shares need to cross this level to recover all the losses for 2026
Cohance Lifesciences shares have advanced in four of the past seven sessions and is now attempting to recover its losses for 2026. The key level to watch is ₹528, which the stock had touched on December 31, 2025.
SBI Card shares fall as analysts cut price targets after subdued Q4
SBI Cards shares fall after Q4, HSBC cuts target to ₹500 with reduce, Jefferies and UBS stay cautious, growth muted, earnings estimates and targets trimmed.